Paroco Medical Equipment d.o.o. continues to record strong business performance, reaffirming its leading position in the supply, installation, and maintenance of advanced medical equipment. Compared to the previous year, the company achieved a 16% increase in turnover, further confirming the effectiveness of its clearly defined long-term strategy and the trust of partners across the region.
More than three decades of proven experience and reliability
Paroco Medical Equipment d.o.o. was founded in 1992 in Novi Sad, with its core activities focused on the import, distribution, and servicing of medical equipment, and the education of end users. Since its establishment, the company has been dedicated to building long-term, exclusive distributorship partnerships with renowned global manufacturers, as well as fostering strong and reliable relationships with healthcare institutions.
This approach has created a strong foundation for continuous growth and innovation, enabling the realization of visionary ideas aimed at advancing and improving the healthcare system.
Comprehensive turnkey solutions
By collaborating with globally recognized manufacturers of high-quality and technologically advanced medical equipment, Paroco Medical Equipment provides comprehensive turnkey solutions for healthcare facilities. The company’s portfolio includes, among others:
- Complete equipping of operating rooms
- Operating tables, surgical lights, and medical furniture
- Anesthesia and ventilation systems
- Hemodynamic monitoring and extracorporeal circulation systems
- Equipment and consumables for HF (high-frequency) surgery
- Flexible, ultrasound, and rigid endoscopy systems
- Laparoscopic and conventional surgical instruments
- Mobile X-ray systems
- Diagnostic systems for urology and gastroenterology
- Equipment for physical medicine and rehabilitation
- Medical monitors
- Hospital beds, stretchers, trolleys, and accompanying medical furniture
Growth across the group and the healthcare system
In addition to the growth of the parent company, outstanding results have also been achieved across the group:
- PAROCO-B Medical Equipment d.o.o. – a 20% increase in turnover
- General Hospital NEW Hospital – a 15% increase in turnover
Paroco Medical Equipment has also successfully delivered major projects in cooperation with leading healthcare institutions in Serbia and across the region. In 2025, the company took a significant strategic step by acquiring Medial Group d.o.o., a highly specialized company focused on the distribution, technical support, and servicing of medical equipment. Medial Group is a market leader in neurological diagnostics support, holding a market share of over 90% in the countries where it operates as an authorized distributor. This acquisition has further strengthened Paroco Medical Equipment’s position in the Serbian market, while plans for 2026 include expansion into the Bosnia and Herzegovina market. This strategic move will further reinforce Paroco’s regional presence, expertise, and long-term commitment to advancing healthcare services.
Looking ahead: 2026 as a year of new milestones
During 2026, Paroco Medical Equipment plans to further expand its business activities in the following areas:
- Robotics
- Neurological equipment
- The launch of a new line of Zoncare ultrasound systems
A major milestone will also be the construction of the new Paroco facility. Construction works commenced in June 2024, with occupancy scheduled for February or March 2026.
View this post on Instagram
In parallel, the reconstruction and expansion of the General Hospital New Hospital are scheduled to begin in March 2026, further underscoring Paroco Medical Equipment’s long-term commitment to the development of healthcare infrastructure.
Partner of the healthcare system of the future
Continuous growth, strategic investments, and a strong focus on innovation position Paroco Medical Equipment as a trusted partner to healthcare institutions and one of the key contributors to the advancement of healthcare services across the region. With a clear vision and strong foundations, the company continues to build the future of medicine.
